1/37
Comprehensive vocabulary flashcards covering the biological, cognitive, and sociocultural etiologies and treatments of Major Depressive Disorder (MDD), as well as epidemiological principles regarding prevalence and health issues.
Genetic Inheritance
The process by which genes are passed from parents to children, referring to the extent to which an offspring's behavior or physical traits are inherited.
Gene
A specific segment of DNA found on a chromosome that acts as the basic unit of heredity determining characteristics of offspring.
Concordance Rates
The probability that one individual in a pair (such as a twin pair) possesses a trait given that the other individual has it.
Monozygotic (MZ) Twins
Identical twins who share 100% of their genetic makeup.
Dizygotic (DZ) Twins
Non-identical (fraternal) twins who share approximately 50% of their genes.
Diathesis-Stress Model
A gene-environment interaction theory asserting that biological factors create a predisposition (diathesis) that requires external environmental triggers (stressors) to manifest as a psychological disorder.
5-HTT Gene
The serotonin-transporter gene involved in mood regulation, possessing short and long allele variants that moderate vulnerability to depression under stress.
Neurotransmission
The chemical and electrical process through which informational signals are relayed from one neuron to another across a synapse.
Action Potential
The electrical impulse generated in the presynaptic neuron that travels down the axon to stimulate the release of neurotransmitters.
Axon Terminal
The specialized structure situated at the distal end of a sender neuron where neurotransmitters are stored and released.
Synaptic Gap
The microscopic physical void separating the presynaptic terminal from the postsynaptic receptor membrane.
Neurotransmitters
Chemical messengers stored in vesicles that diffuse across the synaptic gap to bind to matching receptor sites on a receiver cell.
Reuptake
The biological mechanism where unabsorbed neurotransmitters lingering in the synaptic cleft are reabsorbed by the presynaptic neuron.
Selective Serotonin Reuptake Inhibitors (SSRIs)
Antidepressant pharmaceuticals, such as fluoxetine (Prozac), that block the presynaptic reabsorption of serotonin to heighten its synaptic availability.
Randomized Controlled Trial (RCT)
An experimental research design where subjects are randomly assigned to active treatment or control conditions to measure intervention efficacy.
Response Rate
The percentage of clinical trial patients who demonstrate a 50% or greater reduction in depression rating scores post-treatment.
Remission Rate
The percentage of clinical trial participants who present few or no detectable symptoms of depression at the conclusion of treatment.
Relapse Rate
The percentage of individuals who redevelop depressive symptoms following the cessation of therapeutic intervention.
Placebo Effect
A measurable clinical improvement resulting from an inert substance or sham treatment driven by the participant's psychological expectations.
Double-Blind Experiment
A methodological protocol in which neither the research subjects nor the administering evaluators know who receives the active substance versus the placebo.
Cognitive Appraisals
An individual's subjective interpretation and evaluation of their life experiences and events.
Beck's Negative Cognitive Triad
Depressive cognitive schemas characterized by deeply negative automatic assumptions regarding the Self, the World, and the Future.
Cognitive Behavioral Therapy (CBT)
A problem-solving psychotherapeutic modality that treats negative automatic beliefs as testable hypotheses, integrating cognitive restructuring and behavioral activation.
Cognitive Restructuring
A therapeutic strategy within CBT in which clients identify and substitute distorted, irrational cognitions with objective, balanced appraisals.
Behavioral Activation
A therapeutic CBT component where individuals engage in real-world behavioral exercises to enact coping mechanisms and rebuild positive reinforcement.
Prevalence Rates
The statistical proportion of individuals within a designated population who manifest a specific attribute or disorder during a defined timeframe.
Etiology
The underlying causes, origins, or explanatory factors that precipitate the onset of a disorder or clinical pathology.
Somatization
A clinical phenomenon where psychological pain or affective distress is reported primarily as physical, somatic symptoms such as headaches or stomach distress.
Reporting Bias
A distortion in epidemiological data caused by a patient's reluctance or unwillingness to disclose psychiatric symptoms due to cultural stigma.
Interpretation Bias
Diagnostic inaccuracies emerging when a clinician evaluates a patient's symptoms through their own subjective cultural assumptions.
Cultural Mismatch
A communicative and cultural discrepancy between a mental healthcare provider and a client that impedes accurate symptom appraisal.
Vocal Biomarkers
Objective paralinguistic acoustic properties, such as frequency, loudness, shimmer, and intonation, utilized to evaluate clinical depression across cultures.
Vulnerability Factors (Brown & Harris)
Enduring adverse social conditions—such as maternal loss before age 11, lack of employment, or multiple young children—that heighten susceptibility to depression.
Provoking Agent
An acute, stressful life event (such as employment termination or relationship breakdown) that triggers a depressive episode in vulnerable persons.
Age Effects
Epidemiological variations occurring consistently across a person's lifespan independently of calendar time or generational cohort.
Period Effects
Uniform temporal shifts that simultaneously influence all age brackets and generational cohorts across a wider population at a specific point in time.
Cohort Effects
Variations in health or behavioral prevalence tied specifically to being born within a particular temporal generation or demographic era.
Body Mass Index (BMI)
An anthropometric calculation defined as body mass in kilograms divided by the square of height in meters (BMI=(height in m)2weight in kg), where an index exceeding 30kg/m2 classifies clinical obesity.